TC Biopharm (Holdings) Plc
TCBPY
$0.4898
$0.219881.41%
OTC PK
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 40.51% | -8.33% | 1.89% | -418.90% | 261.19% |
| Total Depreciation and Amortization | -5.59% | -31.71% | -1.87% | 19.66% | -8.56% |
| Total Amortization of Deferred Charges | -- | -- | -5.26% | -- | -- |
| Total Other Non-Cash Items | -84.04% | 33.92% | -1.89% | 112.92% | -70.20% |
| Change in Net Operating Assets | -7,584.43% | -96.19% | -1.88% | 174.79% | -245.91% |
| Cash from Operations | -12.87% | -23.14% | 1.89% | 48.71% | -39.43% |
| Capital Expenditure | -- | -- | -1.95% | 163.43% | 66.83% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -63.38% | 71.71% | 1.95% | 37.86% | -35.53% |
| Cash from Investing | -433.80% | -242.00% | -1.96% | 105.69% | 49.21% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 0.00% | -- | -- |
| Issuance of Common Stock | 176.82% | -46.27% | 0.00% | 85,045.45% | -99.85% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | -124.77% | 0.00% | 35.94% | -91.26% |
| Cash from Financing | 197.23% | -57.90% | -1.89% | 929.82% | -94.21% |
| Foreign Exchange rate Adjustments | -- | -- | -2.27% | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 101.57% | -656.02% | -1.89% | 107.26% | -534.89% |